|TASC Industries (India) Ltd. was incorporated on 16th April 1992 as a Public Limited Company under the Companies Act 1956 at Bombay in the state of Maharshtra. The certificate of commencement of business was obtained on 5th June 1992.
The company has been promoted by Mr. Vijay Thakkar, Mr. Sanjay Thakkar and Mr. Sanjay Sahu to set up a plant for manufacture of Ciprofloxacin, Chloramphenicol and Chloramphenicol Palmoate. The promoterws have been trading in bulk drugs and formulations for the past eight years through their associate concern Tasc Chemical India Pvt. Ltd.
-Company has changed its name from Tasc Pharmaceuticals Ltd. to Marksans Pharma Ltd.
- Marksans Pharma Ltd has informed that the Board of Directors of the Company at its meeting held on October 30, 2006 has appointed Mr V Nagaraj as Additional as well as Whole Time Director (marketing) of the Company.
-Marksans Pharma Limited has appoineted Mr. V. Nagaraj as Additional as well as Whole Time Director (marketing) of the Company.
- The Company has splits its face value from Rs10/- to Rs1/-.
-Registered Office of the Company has been shifted From 601-622, Chintamani Plaza, Mohan Studio Compound, Andheri-Kurla Road, Andheri (E), Mumbai 400 099 To 21st Floor, Lotus Business Park, Off New Link Road, Andheri (W), Mumbai 400 0530.
-"Marksans Pharma Limited announces USFDA approval of generic Ibuprofen Capsules (Liquid Filled), 200 mg for Advil Liqui - Gels 200 mg."
-Company has entered into a Business Transfer Agreement with Kores (India) Limited
-Registered Office of the Company has been shifted From 21st Floor, Lotus Business park, Off New Link Road, Andheri (W), Mumbai - 400053 To 11th Floor, Lotus Business Park, Off New Link Road, Andheri (W), Mumbai - 400053.
-Dr. Balwant Shankarrao Desai has been appointed as a Whole-time Director of the Company
- Mr. Ajay S. Joshi has been appointed as a Director of the Company
-Marksans Pharma Ltd has appointed Mr. Naresh Balwant Wadhwa as an additional Director of the Company. Mr. Wadhwa will be an independent non-executive director.
-Marksans Pharma Ltd has recommended dividend of 10% which is Rs. 0.10 per equity share of Rs. 1/- each face value.
-The Registered office of the company has been shifted from old location to 11th Floor, "GRANDEUR", Opp. Gundeecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai -400053, Telephone: +91 22 4001 2000,Telefax: +91 224001 2011, E-mail: firstname.lastname@example.org
-Marksans Pharma gains on acquiring Time-Cap Laboratories
-Marksans Pharma gets USFDA nod for Paricalcitol capsules
-Marksans Pharma gets USFDA nod for diabetes treatment drug
-Marksans Pharma bags USFDA approval for Loratadine